MB Therapeutics awarded France 2030 project grant: accelerating innovation in healthcare
€500,000 to industrialize our pharmaceutical inks and equip the first pilot pharmacies by 2026. Discover how this strategic support will accelerate our deployment.
MB Therapeutics strengthens its growth strategy with the appointment of a Chief Business Officer
Meet our Chief Business Officer, appointed to accelerate our commercial development and expand our model internationally.
Rheology and pharmaceutical 3D printing specialist appointed R&D engineer at MB Therapeutics
Discover the journey of Morenikeji Aina, joining MB Therapeutics to help accelerate innovation in pharmaceutical formulation.
MB Therapeutics at the heart of innovation at SantExpo 2025
MB Therapeutics is one of the startups highlighted at SantExpo 2025 alongside the University of Montpellier’s Innovation Hub (PUI).